Preserved cross-bridge kinetics in human hypertrophic cardiomyopathy patients with MYBPC3 mutations

被引:11
作者
van Dijk, Sabine J. [1 ]
Boontje, Nicky M. [1 ]
Heymans, Martijn W. [2 ]
ten Cate, Folkert J. [3 ]
Michels, Michelle [3 ]
dos Remedios, Cris [4 ]
Dooijes, Dennis [5 ]
van Slegtenhorst, Marjon A. [6 ]
van der Velden, Jolanda [1 ,7 ]
Stienen, Ger J. M. [1 ,8 ]
机构
[1] Vrije Univ Amsterdam Med Ctr, Physiol Lab, Inst Cardiovasc Res, NL-1081 BT Amsterdam, Netherlands
[2] Vrije Univ Amsterdam Med Ctr, Dept Epidemiol & Biostat, NL-1081 BT Amsterdam, Netherlands
[3] Erasmus MC, Ctr Thorax, Rotterdam, Netherlands
[4] Univ Sydney, Muscle Res Unit, Inst Biomed Res, Sydney, NSW 2006, Australia
[5] Med Ctr Utrecht, Utrecht, Netherlands
[6] Erasmus MC, Rotterdam, Netherlands
[7] ICIN Netherlands Heart Inst, Utrecht, Netherlands
[8] Vrije Univ Amsterdam, Dept Phys & Astron, Amsterdam, Netherlands
来源
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY | 2014年 / 466卷 / 08期
关键词
Cardiac muscle; Cross-bridge; Muscle contraction; MyBP-C mutation; BINDING-PROTEIN-C; KINASE-A PHOSPHORYLATION; HEART-FAILURE; TROPONIN-I; STRETCH ACTIVATION; F-ACTIN; MYOSIN; MUSCLE; ABLATION; GENE;
D O I
10.1007/s00424-013-1391-0
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Mutations in the MYBPC3 gene, encoding cardiac myosin binding protein C (cMyBP-C) are frequent causes of hypertrophic cardiomyopathy (HCM). Previously, we have presented evidence for reduced cMyBP-C expression (haploinsufficiency), in patients with a truncation mutation in MYBPC3. In mice, lacking cMyBP-C cross-bridge kinetics was accelerated. In this study, we investigated whether cross-bridge kinetics was altered in myectomy samples from HCM patients harboring heterozygous MYBPC3 mutations (MYBPC3(mut)). Isometric force and the rate of force redevelopment (k (tr)) at different activating Ca2+ concentrations were measured in mechanically isolated Triton-permeabilized cardiomyocytes from MYBPC3(mut) (n = 18) and donor (n = 7) tissue. Furthermore, the stretch activation response of cardiomyocytes was measured in tissue from eight MYBPC3(mut) patients and five donors to assess the rate of initial force relaxation (k (1)) and the rate and magnitude of the transient increase in force (k (2) and P (3), respectively) after a rapid stretch. Maximal force development of the cardiomyocytes was reduced in MYBPC3(mut) (24.5 +/- 2.3 kN/m(2)) compared to donor (34.9 +/- 1.6 kN/m(2)). The rates of force redevelopment in MYBPC3(mut) and donor over a range of Ca2+ concentrations were similar (k (tr) at maximal activation: 0.63 +/- 0.03 and 0.75 +/- 0.09 s(-1), respectively). Moreover, the stretch activation parameters did not differ significantly between MYBPC3(mut) and donor (k (1): 8.5 +/- 0.5 and 8.8 +/- 0.4 s(-1); k (2): 0.77 +/- 0.06 and 0.74 +/- 0.09 s(-1); P (3): 0.08 +/- 0.01 and 0.09 +/- 0.01, respectively). Incubation with protein kinase A accelerated k (1) in MYBPC3(mut) and donor to a similar extent. Our experiments indicate that, at the cMyBP-C expression levels in this patient group (63 +/- 6 % relative to donors), cross-bridge kinetics are preserved and that the depressed maximal force development is not explained by perturbation of cross-bridge kinetics.
引用
收藏
页码:1619 / 1633
页数:15
相关论文
共 59 条
  • [1] The 2373insG mutation in the MYBPC3 gene is a founder mutation, which accounts for nearly one-fourth of the HCM cases in the Netherlands
    Alders, M
    Jongbloed, R
    Deelen, W
    van den Wijngaard, A
    Doevendans, P
    Ten Cate, F
    Regitz-Zagrosek, V
    Vosberg, HP
    van Langen, I
    Wilde, A
    Dooijes, D
    Mannens, M
    [J]. EUROPEAN HEART JOURNAL, 2003, 24 (20) : 1848 - 1853
  • [2] Phosphorylation and function of cardiac myosin binding protein-C in health and disease
    Barefield, David
    Sadayappan, Sakthivel
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2010, 48 (05) : 866 - 875
  • [3] Troponin I phosphorylation in the normal and failing adult human heart
    Bodor, GS
    Oakeley, AE
    Allen, PD
    Crimmins, DL
    Ladenson, JH
    Anderson, PAW
    [J]. CIRCULATION, 1997, 96 (05) : 1495 - 1500
  • [4] Cardiomyocyte stiffness in Diastolic heart failure
    Borbély, A
    van der Velden, J
    Papp, Z
    Bronzwaer, JGF
    Edes, I
    Stienen, GJM
    Paulus, WJ
    [J]. CIRCULATION, 2005, 111 (06) : 774 - 781
  • [6] Organization and sequence of human cardiac myosin binding protein C gene (MYBPC3) and identification of mutations predicted to produce truncated proteins in familial hypertrophic cardiomyopathy
    Carrier, L
    Bonne, G
    Bahrend, E
    Yu, B
    Richard, P
    Niel, F
    Hainque, B
    Cruaud, C
    Gary, F
    Labeit, S
    Bouhour, JB
    Dubourg, O
    Desnos, M
    Hagege, AA
    Trent, RJ
    Komajda, M
    Fiszman, M
    Schwartz, K
    [J]. CIRCULATION RESEARCH, 1997, 80 (03) : 427 - 434
  • [7] Protein kinase A-induced myofilament desensitization to Ca2+ as a result of phosphorylation of cardiac myosin-binding protein C
    Chen, Peter P.
    Patel, Jitandrakumar R.
    Rybakova, Inna N.
    Walker, Jeffery W.
    Moss, Richard L.
    [J]. JOURNAL OF GENERAL PHYSIOLOGY, 2010, 136 (06) : 615 - 627
  • [8] Impact of temperature on cross-bridge cycling kinetics in rat myocardium
    de Tombe, Pieter P.
    Stienen, G. J. A.
    [J]. JOURNAL OF PHYSIOLOGY-LONDON, 2007, 584 (02): : 591 - 600
  • [9] A molecular map of the interactions between titin and myosin-binding protein C - Implications for sarcomeric assembly in familial hypertrophic cardiomyopathy
    Freiburg, A
    Gautel, M
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1996, 235 (1-2): : 317 - 323
  • [10] PHOSPHORYLATION SWITCHES SPECIFIC FOR THE CARDIAC ISOFORM OF MYOSIN BINDING PROTEIN-C - A MODULATOR OF CARDIAC CONTRACTION
    GAUTEL, M
    ZUFFARDI, O
    FREIBURG, A
    LABEIT, S
    [J]. EMBO JOURNAL, 1995, 14 (09) : 1952 - 1960